WuXi Biologics (Cayman) Inc. (WXXWY)
USD 4.3
(-1.15%)
USD 4.3
(-1.15%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 3.39 Billion CNY | -23.09% |
| 2022 | 4.42 Billion CNY | 30.45% |
| 2021 | 3.38 Billion CNY | 100.63% |
| 2020 | 1.68 Billion CNY | 66.59% |
| 2019 | 1.01 Billion CNY | 60.77% |
| 2018 | 630.59 Million CNY | 149.61% |
| 2017 | 252.62 Million CNY | 79.05% |
| 2016 | 141.09 Million CNY | 217.01% |
| 2015 | 44.5 Million CNY | 6.03% |
| 2014 | 41.97 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 1.49 Billion CNY | 0.0% |
| 2023 Q4 | 1.13 Billion CNY | 0.0% |
| 2023 FY | 3.39 Billion CNY | -23.09% |
| 2023 Q2 | 2.26 Billion CNY | 0.0% |
| 2022 FY | 4.42 Billion CNY | 30.45% |
| 2022 Q2 | 2.53 Billion CNY | 0.0% |
| 2022 Q4 | 1.88 Billion CNY | 0.0% |
| 2021 Q4 | 1.54 Billion CNY | 0.0% |
| 2021 Q2 | 1.84 Billion CNY | 0.0% |
| 2021 FY | 3.38 Billion CNY | 100.63% |
| 2020 Q2 | 736.11 Million CNY | 0.0% |
| 2020 FY | 1.68 Billion CNY | 66.59% |
| 2020 Q4 | 952.77 Million CNY | 0.0% |
| 2019 FY | 1.01 Billion CNY | 60.77% |
| 2019 Q4 | 563.76 Million CNY | 0.0% |
| 2019 Q2 | 450.04 Million CNY | 0.0% |
| 2018 FY | 630.59 Million CNY | 149.61% |
| 2018 Q4 | 381.02 Million CNY | 0.0% |
| 2018 Q2 | 249.57 Million CNY | 0.0% |
| 2017 FY | 252.62 Million CNY | 79.05% |
| 2017 Q2 | 92.19 Million CNY | 0.0% |
| 2017 Q4 | 160.43 Million CNY | 0.0% |
| 2016 Q2 | 83.85 Million CNY | 0.0% |
| 2016 Q4 | 57.24 Million CNY | 0.0% |
| 2016 FY | 141.09 Million CNY | 217.01% |
| 2015 Q4 | 11.12 Million CNY | 0.0% |
| 2015 FY | 44.5 Million CNY | 6.03% |
| 2015 Q1 | 11.12 Million CNY | 6.03% |
| 2015 Q2 | 11.12 Million CNY | 0.0% |
| 2015 Q3 | 11.12 Million CNY | 0.0% |
| 2014 Q3 | 10.49 Million CNY | 0.0% |
| 2014 Q1 | 10.49 Million CNY | 0.0% |
| 2014 FY | 41.97 Million CNY | 0.0% |
| 2014 Q4 | 10.49 Million CNY | 0.0% |
| 2014 Q2 | 10.49 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 4635.209% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | 51798.169% |
| SQZ Biotechnologies Company | -79.46 Million USD | 4378.326% |
| Evofem Biosciences, Inc. | 52.97 Million USD | -6317.126% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | -5119.678% |
| Mesoblast Limited | -87.95 Million USD | 3965.261% |
| Propanc Biopharma, Inc. | -1.82 Million USD | 186844.12% |
| Genus plc | 7.9 Million USD | -42934.544% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | 31313.825% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | 91731.121% |
| Marizyme, Inc. | -65.34 Million USD | 5302.585% |
| ContraFect Corporation | -65.15 Million USD | 5318.07% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | 38541.079% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | 69680.13% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | 196905.648% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | 117640.314% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | 42281.925% |
| MultiCell Technologies, Inc. | -380.07 USD | 894500849.862% |
| Accustem Sciences Inc. | -3.74 Million USD | 90846.096% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 6676.896% |
| EV Biologics, Inc. | -1.26 Million USD | 268400.669% |
| Q BioMed Inc. | -2.05 Million USD | 165771.293% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | 91172.301% |
| Neon Bloom, Inc. | -632.4 Thousand USD | 537685.605% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | 142893.559% |
| Biomind Labs Inc. | -1.21 Million USD | 280070.008% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | -10.54 Million USD | 32331.03% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | 43117.702% |
| Skye Bioscience, Inc. | -37.64 Million USD | 9131.076% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | 156782.969% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | 22701281.891% |
| Arch Therapeutics, Inc. | -6.98 Million USD | 48786.938% |
| IMV Inc. | -36.48 Million USD | 9417.978% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | 21520.415% |
| Curative Biotechnology, Inc. | -5.81 Million USD | 58542.172% |
| GB Sciences, Inc. | -1.36 Million USD | 249772.206% |
| Alpha Cognition Inc. | -13.77 Million USD | 24784.788% |
| HST Global, Inc. | -146.21 Thousand USD | 2325336.988% |
| CSL Limited | 2.64 Billion USD | -28.68% |
| Halberd Corporation | -79.67 Thousand USD | 4267042.367% |
| Enzolytics Inc. | -2.17 Million USD | 156277.831% |
| Resverlogix Corp. | -3.61 Million USD | 94275.319% |
| Affymax, Inc. | -14.42 Million USD | 23669.946% |
| SYBLEU INC | -180.3 Thousand USD | 1885653.842% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | 107298.411% |
| argenx SE | -295.05 Million USD | 1252.243% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 5530.964% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | -3469011.224% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | 85670.979% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | 112445.583% |
| AVAX Technologies, Inc. | -6.41 Million USD | 53107.727% |
| Zenith Capital Corp. | -10.59 Million USD | 32185.023% |
| Genscript Biotech Corporation | -95.47 Million USD | 3660.783% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | 14627623.449% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | 82101.483% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | 5625008.485% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 5792.267% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | 109706.167% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | -1.05 Million USD | 322026.657% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | 174512.248% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | 89121.445% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | 169652.819% |
| BioStem Technologies, Inc. | -8.48 Million USD | 40177.041% |
| ONE Bio Corp. | 8.67 Million USD | -39082.679% |
| Reve Technologies, Inc. | -441.36 Thousand USD | 770369.095% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | 254679.158% |
| Wesana Health Holdings Inc. | -1.75 Million USD | 193842.032% |
| Agentix Corp. | -1.37 Million USD | 247494.978% |
| LadRx Corporation | 400.44 Thousand USD | -848891.991% |
| Cell Source, Inc. | -5.32 Million USD | 63990.125% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | 818367.349% |
| Regen BioPharma, Inc. | 1.02 Million USD | -332064.38% |
| Regen BioPharma, Inc. | 1.02 Million USD | -332064.38% |
| NovAccess Global Inc. | -4.76 Million USD | 71385.295% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | -48996.438% |
| Itoco Inc. | -1.86 Million USD | 182001.45% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | 76626.78% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | 203798.562% |
| Kadimastem Ltd | -3.3 Million USD | 102891.651% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | 1243590.904% |
| CytoDyn Inc. | -49.84 Million USD | 6921.149% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | 4301757.535% |
| Mobile Lads Corp. | -2.26 Million USD | 150311.683% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | 1490379.099% |
| Qrons Inc. | -789.34 Thousand USD | 430801.453% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | 361185.957% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | -2.08 Million USD | 162947.072% |
| Rebus Holdings, Inc. | -1.02 Million USD | 333406.765% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | 210904.924% |
| International Stem Cell Corporation | -131 Thousand USD | 2595312.977% |
| Bioxytran, Inc. | -4.28 Million USD | 79532.883% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | 6264341.229% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | 134463.523% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 7172.161% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | 160919.726% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | -780.88 Thousand USD | 435467.601% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | 107414.678% |
| Neutra Corp. | -233.46 Thousand USD | 1456304.999% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 16854.862% |
| PureTech Health plc | -65.69 Million USD | 5274.862% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | 16086.284% |
| IXICO plc | -1.17 Million USD | 288701.783% |
| IntelGenx Technologies Corp. | -9.92 Million USD | 34347.295% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 6051.073% |
| CSL Limited | 2.64 Billion USD | -28.68% |
| Cellectis S.A. | -103.17 Million USD | 3395.146% |